Dr. Reddy’s (NYSE: RDY) schedules 42nd AGM and ₹8 per share dividend
Rhea-AI Filing Summary
Dr. Reddy’s Laboratories Limited has informed shareholders about its 42nd Annual General Meeting and related shareholder communication. The AGM will be held on July 23, 2026 at 11:00 a.m. IST through video conferencing and other audio-visual means.
The company’s Notice and Integrated Annual Report for financial year 2025-26 are available online via a provided web link and QR code, and letters are being sent to shareholders without registered email addresses. The board has proposed a final dividend of ₹8 per equity share, with a record date of July 10, 2026 and payment on or before July 30, 2026.
The filing also provides e-voting details, with eligibility set by a cut-off date of July 16, 2026 and remote e-voting available from July 19 to July 22, 2026. Shareholders are requested to update their KYC details with their depository participants or the company’s registrar and transfer agent, and contact details for the registrar are provided for queries and service requests.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Integrated Annual Report financial
Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regulatory
Video Conferencing (VC)/Other Audio Visual Means (OAVM) technical
Record date financial
E-voting regulatory
KYC financial
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
June, 2026
Commission File Number 1-15182
DR. REDDY’S LABORATORIES LIMITED
(Translation of registrant’s name into English)
8-2-337, Road No. 3, Banjara Hills
Hyderabad, Telangana 500 034, India
+91-40-49002900
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.
EXHIBITS
| Exhibit Number | Description of Exhibits | |
| 99.1 | Intimation dated June 30, 2026 |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
DR. REDDY’S LABORATORIES LIMITED (Registrant) | |||
| Date: June 30, 2026 | By: | /s/ K Randhir Singh | |
| Name: | K Randhir Singh | ||
| Title: | Company Secretary | ||
| 3 |
Exhibit 99.1
 |
Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India
CIN: L85195TG1984PLC004507
Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com |
June 30, 2026
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Sub: Compliance under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) – Letter to shareholders in relation to Integrated Annual Report of the Company for FY 2025-26
Pursuant to Regulation 36(1)(b) of the SEBI Listing Regulations, letters are being sent to those shareholders who have not registered their email addresses with the Company or the Registrar and Share Transfer Agent or the Depository Participant(s), providing the weblink for accessing the Notice of the 42nd Annual General Meeting and Integrated Annual Report of the Company for the financial year 2025-26.
The above referred letter in this regard is enclosed. You are requested to take the above information on record.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer and Head-CSR
|
Dr. Reddy’s Laboratories Limited CIN: L85195TG1984PLC004507 Registered Office: 8-2-337, Road No. 3, Banjara Hills, Hyderabad – 500 034, Telangana, India. Tel : +91 40 49002900, Fax : +91 40 49002999 Email : shares@drreddys.com | Website : www.drreddys.com |
| 42nd Annual General Meeting |
| We are pleased to inform you that the 42nd Annual General Meeting (“AGM”) of the Company will be held on Thursday, July 23, 2026, at 11:00 a.m. (1ST) through Video Conferencing (“VC”)/Other Audio Visual Means (“OAVM”). |
| The Notice and Integrated Annual Report for Financial Year 2025-26 is available and can be downloaded from below link and QR code: https://www.drreddys.com/cms/sites/default/files/2026-06/Integrated Annual Report 2025-26.pdf |
 |
| Final Dividend for FY 2025-26: | |
| Amount of Dividend | ₹8 per equity share |
| Record date | Friday, July 10, 2026 |
| Payment date | On or before July 30, 2026 |
| You are requested to update and complete your KYC* details with: |
· Depository Participants (DPs), if shares held in electronic form: |
· Company I Registrar and Transfer Agent (“RTA”) through Service request, if shares held in physical form: |
| *(including name, postal address, email ID, telephone/mobile numbers, PAN, mandates, nominations, power of attorney and Bank Details) |
| E-voting Details: | |
| Cut-off date to determine entitlement for e-voting | Thursday, July 16, 2026 |
| E-voting start date and time | Sunday, July 19, 2026 (9:00 a.m. IST) |
| E-voting end date and time | Wednesday, July 22, 2026 (5:00 p.m. IST) |
| Refer to instructions for Members for Attending the EGM/AGM Through VC/OAVM of 42nd AGM Notice to know the procedure for Speaker registration, e-voting and to join virtual AGM |
| Members who are attending the AGM and have not cast their vote during remote e-voting period, can vote on the resolutions during the AGM |
| Correspondence/Queries: |
All queries to be addressed to the Company’s RTA: Bigshare Services Private Limited Unit - Dr. Reddy’s Laboratories Limited 306, Right Wing, 3rd Floor, Amrutha Ville, Opp. Yashoda Hospital, Rajbhavan Road, Hyderabad 500 082, Telangana, India. Tel: +91-40-2337 4967, 4014 4967 You may also send service request to email id bsshyd@bigshareonline.com |
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
Sd/
K Randhir Singh
Company Secretary, Compliance Officer & Head-CSR
Membership Number: F6621